Urinalysis Market: By Product Type (Urine Analyzer, POC, Dipstick, Reagent), By Test Type (Biochemical, Sediment, Microscopic), By Application (Kidney, Liver Disease, Pregnancy, Diabetes, UTI), By End User (Hospitals, Research Institute, Others), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Urinalysis Market size was valued at USD 3.6 billion in 2021. It is expected to reach a value of USD 5.0 billion by 2028, growing at a CAGR of 7.3%. during 2023-2029. Urinalysis is an investigation of urine. The urinalysis test incorporates different investigation for conclusion of some normal malady, for example, urinary tract contaminations, kidney issue, diabetes, and liver issues. In such restorative conditions, urinalysis testing includes synthetic, visual, and minuscule examinations to identify cell pieces and substances, for example, gems or throws in the pee. This test is presumably utilized for the location of diabetes as pervasiveness of diabetic cases is rising step by step. The urinalysis test market is exceedingly divided and depends on new item dispatches and clinical consequences of items. Henceforth the real players have utilized different procedures, for example, new item dispatches, clinical preliminaries, showcase activities, high cost on innovative work, understandings, joint endeavors, organizations, acquisitions, and others to build their impressions in this market. Market members are always occupied with the presentation of novel demonstrative items trying to guarantee their supportability and increment the entrance of their item portfolio.  

The Urinalysis Market Key Developments:

  • In June 2014, Roche propelled a completely robotized pee testing analyzer named Cobas 6500 with a goal to improve staff wellbeing and increment the outcome dependability.  
  • In January 2016, Sysmex has launches the UC-3500 Fully-Automated Urine Chemistry Analyzer.

Urinalysis Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Urinalysis Market Dynamics

Increase in the prevalence of kidney related diseases and urinary tract infections is the key factor attributing the growth of the urinalysis market. Growing geriatric population along with growing kidney disorders is anticipating the growth of the market. Technological advancements are anticipating the growth of the market in this region. Increase in the awareness among the patient population regarding the modern treatment techniques is adding fuel for the growth of the market. However, the stringent government regulations are restraining the growth of the market. The higher cost associated with the research and development is hampering the growth of the urinalysis market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Urinalysis Market Segmentation

By Product Type
  • Urine Analyzer
  • POC
  • Dipstick
  • Reagent
By Test Type
  • Biochemical
  • Sediment
  • Microscopic
By Application
  • Kidney
  • Liver Disease
  • Pregnancy
  • Diabetes
  • UTI
By End User
  • Hospitals
  • Research Institute
  • Others

Frequently Asked Questions

The global urinalysis market size was valued at USD 3.6 billion in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Arkray, Inc. (Japan)
  • Siemens AG (Germany)
  • Sysmex (Japan)
  • Beckman Coulter (U.S.)
  • Roche Diagnostics (Switzerland)
  • Acon Laboratories Inc. (U.S)
  • Bio-Rad Laboratories Inc. (U.S)